Page last updated: 2024-11-04

vorinostat and Polyploid

vorinostat has been researched along with Polyploid in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research Excerpts

ExcerptRelevanceReference
"The induction of polyploidy was more marked in HCT116 p21WAF1-/- or HCT116 p53-/- cells than in wild-type HCT116."1.33Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects. ( Gui, CY; Marks, PA; Ngo, L; Perez, G; Xu, WS, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, WS1
Perez, G1
Ngo, L1
Gui, CY1
Marks, PA1

Other Studies

1 other study available for vorinostat and Polyploid

ArticleYear
Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects.
    Cancer research, 2005, Sep-01, Volume: 65, Issue:17

    Topics: Antineoplastic Agents; Cell Death; Cell Growth Processes; Colonic Neoplasms; DNA Replication; Enzyme

2005